Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance

Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and...

Descripción completa

Detalles Bibliográficos
Autor principal: White, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777025/
https://www.ncbi.nlm.nih.gov/pubmed/31581941
http://dx.doi.org/10.1186/s12936-019-2955-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777025/
https://www.ncbi.nlm.nih.gov/pubmed/31581941
http://dx.doi.org/10.1186/s12936-019-2955-z

Ejemplares similares